Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study

Yashashwi Pokharel, Wensheng Sun, Linda M. Polfus, Aaron R. Folsom, Gerardo Heiss, A. Richey Sharrett, Eric Boerwinkle, Christie M. Ballantyne, Ron C. Hoogeveen

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Objective: Lipoprotein-associated phospholipase A2 (LpPLA2) activity was associated with higher CHD risk in a meta-analysis, which was partly dependent on circulating lipid levels. Apolipoprotein C3 loss-of-function (ApoC3 LOF) mutations were related with reduced postprandial lipemia and CHD risk. However, the association of LpPLA2 activity with ApoC3 LOF is not known. Methods: We examined the association of LpPLA2 activity and ApoC3 LOF mutations and incident cardiovascular disease (CVD) (defined as coronary heart disease [CHD] plus ischemic stroke) and all-cause mortality in the biracial longitudinal Atherosclerosis Risk In Communities (ARIC) study. Results: The mean LpPLA2 activity was 229.3nmol/min/mL and was higher in men and whites. LpPLA2 activity correlated positively with atherogenic dyslipidemia. ApoC3 LOF carriers had lower LpPLA2 activity levels compared to non-carriers, and there was inverse association between LpPLA2 activity and ApoC3 LOF mutations in whites. In a fully adjusted model, greater LpPLA2 activity was independently associated with incident CVD (HR 1.35, 1.09-1.68 for highest vs. lowest quintile), which was mainly explained by its association with CHD, and was also associated with all-cause mortality (HR 1.65, 1.38-1.98). Conclusions: Greater LpPLA2 activity was associated with increased CHD and all-cause mortality in both whites and African-Americans in the ARIC study. The inverse relation between LpPLA2 activity and ApoC3 LOF mutations suggests that delayed lipoprotein clearance may at least in part explain the observed association of LpPLA2 activity with increased CVD risk.

Original languageEnglish (US)
Pages (from-to)641-648
Number of pages8
JournalAtherosclerosis
Volume241
Issue number2
DOIs
StatePublished - Aug 1 2015

Keywords

  • ARIC
  • ApoB
  • ApoC3 LOF
  • Apolipoprotein C3 loss-of-function
  • Atherogenic dyslipidemia
  • Atherosclerosis Risk In Communities Study
  • CHD
  • CVD
  • Cardiovascular disease
  • Coronary heart disease
  • HDL-C
  • Ischemic stroke
  • LDL(C)
  • Lipoprotein-associated phospholipase A activity
  • LpPLA
  • PLA2G7
  • PtdCho
  • SOLID-TIMI 52
  • STABILITY
  • SdLDL-C

Fingerprint Dive into the research topics of 'Lipoprotein associated phospholipase A<sub>2</sub> activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study'. Together they form a unique fingerprint.

Cite this